HR 8588
Improving the American Drug Supply Chain Act of 2020
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill directs the Department of Health and Human Services to commission a study by the National Academies of Sciences, Engineering, and Medicine. The study will examine the current and historical production of drugs and key ingredients both in the United States and abroad, aiming to identify reasons for drug production locations and recommend ways to increase domestic production and mitigate risks to the drug supply chain, particularly during public health emergencies. The report will consider economic, regulatory, and international factors.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Lisa [D-DE-At Large] Blunt Rochester
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.